Clinical Trials Directory

Trials / Completed

CompletedNCT02088697

A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Otsuka Pharmaceutical Co., Ltd. · Industry
Sex
Male
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the bioequivalence of ASC-01 Placebo and sertraline Tablet in Japanese healthy male subjects.

Conditions

Interventions

TypeNameDescription
DRUGPlacebo
DRUGASC-01

Timeline

Start date
2013-12-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2014-03-17
Last updated
2021-06-03
Results posted
2021-06-03

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02088697. Inclusion in this directory is not an endorsement.

A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Sub (NCT02088697) · Clinical Trials Directory